Menu

Are All Neurodegenerative Diseases Made Equal?

The Scientist is bringing together a panel of experts to share their research, discuss current therapeutic approaches, and to offer their insights.

Jan 2, 2018
The Scientist Creative Services Team

Are All Neurodegenerative Diseases Made Equal? from thescientistllc on Vimeo.


Various neurodegenerative processes result in the development of diseases like Alzheimer’s (AD), Parkinson’s (PD), amyotrophic lateral sclerosis (ALS), and, arguably, multiple sclerosis (MS). Despite years of research, drug discovery initiatives, and promising clinical trials, these diseases remain incurable. But recent studies have suggested common mechanisms underlying these pathologies. Atypical protein assembly resulting in plaque formation is a common pathological finding in both AD and PD, while neuronal death is a primary (ALS) or secondary (MS) hallmark of disease. For a detailed look at the mechanisms that drive an array of neurodegenerative diseases, The Scientist is bringing together a panel of experts to share their research, discuss current therapeutic approaches, and offer their insights. Come engage with our panel and get the answers you seek.

Topics to be covered:

  • The molecular and mechanistic similarities and differences between neurodegenerative diseases
  • Whether primary and secondary neurodegeneration distinctions are based on biology

Meet the Speakers:

Rudolph E. Tanzi, PhD
Joseph. P. and Rose F. Kennedy Professor of Neurology
Harvard Medical School
Vice-Chair, Department of Neurology; Director, Genetics and Aging Research Unit
Massachusetts General Hospital

 

Gregory A. Petsko, DPhil
Mahon Professor, Department of Neurology and Neuroscience
Director, Appel Alzheimer’s Disease Research Institute
Weill Cornell Medicine

 

Bruce D. Trapp, PhD
Chair, Department of Neurosciences
Lerner Research Institute
Cleveland Clinic

 



 

 

 

 

 

 

 

 

 

 

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.